These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23924312)

  • 21. Outcomes of patients with end-stage renal disease (ESRD) under chronic hemodialysis requiring continuous renal replacement therapy (CRRT) and patients without ESRD in acute kidney injury requiring CRRT: a single-center study.
    Jung YS; Lee J; Shin HS; Rim H
    Hemodial Int; 2012 Oct; 16(4):456-64. PubMed ID: 22541135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prognostic value of N terminal pro B type natriuretic peptide in critically ill patients].
    Li ZH; Xiao J; Li JZ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2011 Mar; 23(3):179-82. PubMed ID: 21366951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of volume load on prognosis of patients with sepsis induced acute kidney injury].
    Zhang XQ; Tian HH; Geng HM; Zhai NL; Li Z; Wang T; Lv CJ; Wang XZ
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Jul; 25(7):411-4. PubMed ID: 23834939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery.
    Rajagopalan S; Croal BL; Bachoo P; Hillis GS; Cuthbertson BH; Brittenden J
    J Vasc Surg; 2008 Oct; 48(4):912-7; discussion 917. PubMed ID: 18586440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-terminal-pro-BNP in critically ill patients with acute respiratory failure: a prospective cohort study.
    Okkonen M; Varpula M; Linko R; Perttilä J; Varpula T; Pettilä V;
    Acta Anaesthesiol Scand; 2011 Jul; 55(6):749-57. PubMed ID: 21480833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry.
    Sutherland SM; Zappitelli M; Alexander SR; Chua AN; Brophy PD; Bunchman TE; Hackbarth R; Somers MJ; Baum M; Symons JM; Flores FX; Benfield M; Askenazi D; Chand D; Fortenberry JD; Mahan JD; McBryde K; Blowey D; Goldstein SL
    Am J Kidney Dis; 2010 Feb; 55(2):316-25. PubMed ID: 20042260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluid overload correction and cardiac history influence brain natriuretic peptide evolution in incident haemodialysis patients.
    Chazot C; Vo-Van C; Zaoui E; Vanel T; Hurot JM; Lorriaux C; Mayor B; Deleaval P; Jean G
    Nephrol Dial Transplant; 2011 Aug; 26(8):2630-4. PubMed ID: 21273234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population.
    Kotanidou A; Karsaliakos P; Tzanela M; Mavrou I; Kopterides P; Papadomichelakis E; Theodorakopoulou M; Botoula E; Tsangaris I; Lignos M; Ikonomidis I; Ilias I; Armaganidis A; Orfanos SE; Dimopoulou I
    Shock; 2009 Apr; 31(4):342-7. PubMed ID: 18791494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NT-proBNP Is Predictive of the Weaning from Continuous Renal Replacement Therapy.
    Han SS; Bae E; Song SH; Kim DK; Kim YS; Han JS; Joo KW
    Tohoku J Exp Med; 2016 May; 239(1):1-8. PubMed ID: 27109635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R; Tura BR; Maisel AS
    Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma B-type natriuretic peptide in dialyzed patients: marker of cardiovascular disease or link to plasma refilling.
    De Mauri A; Bellomo G; Navino C; David P; Chiarinotti D; Capurro F; Brustia M; De Maria M; Ruva CE; Ciardi L; De Leo M
    J Nephrol; 2011; 24(4):507-14. PubMed ID: 21240867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis.
    Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M
    J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing for initiation of continuous renal replacement therapy in patients with septic shock and acute kidney injury.
    Shum HP; Chan KC; Kwan MC; Yeung AW; Cheung EW; Yan WW
    Ther Apher Dial; 2013 Jun; 17(3):305-10. PubMed ID: 23735146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.
    Selim G; Stojceva-Taneva O; Spasovski G; Georgievska-Ismail L; Zafirovska-Ivanovska B; Gelev S; Dzekova P; Trajcevska L; Trojacanec-Piponska S; Sikole A
    Nephron Clin Pract; 2011; 119(2):c162-70. PubMed ID: 21757955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma B-type natriuretic peptide level predicts kidney prognosis in patients with predialysis chronic kidney disease.
    Yasuda K; Kimura T; Sasaki K; Obi Y; Iio K; Yamato M; Rakugi H; Isaka Y; Hayashi T
    Nephrol Dial Transplant; 2012 Oct; 27(10):3885-91. PubMed ID: 23114906
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery.
    Hutfless R; Kazanegra R; Madani M; Bhalla MA; Tulua-Tata A; Chen A; Clopton P; James C; Chiu A; Maisel AS
    J Am Coll Cardiol; 2004 May; 43(10):1873-9. PubMed ID: 15145114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
    Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
    Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum urea concentration is probably not related to outcome in ICU patients with AKI and renal replacement therapy.
    De Corte W; Vanholder R; Dhondt AW; De Waele JJ; Decruyenaere J; Danneels C; Claus S; Hoste EA
    Nephrol Dial Transplant; 2011 Oct; 26(10):3211-8. PubMed ID: 21421593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.